Who has invested in Helaina?

Spark Capital, Plum Ventures are named among the investors backing Helaina.

Helaina Funding: $38M Raised, Series B (2024)

Helaina funding overview

Helaina is a Biotech company based in New York, NY. Helaina has raised $38M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2024. The round record for Helaina runs through 2024; nothing later has been disclosed. Investors on record include Spark Capital, Plum Ventures. 2 distinct backers are named across the disclosed rounds.

Helaina at a glance

Total raised: $38M
Latest round: Series B
Latest round date: January 2024
Industry: Biotech
Headquarters: New York, NY
Notable investors: Spark Capital, Plum Ventures

Frequently asked about Helaina funding

How much has Helaina raised?: Helaina has raised $38M in total disclosed funding across the rounds on record.
Who has invested in Helaina?: Spark Capital, Plum Ventures are named among the investors backing Helaina.
What was the latest Helaina funding round?: The most recent disclosed round is a Series B, announced in January 2024.
Where is Helaina based?: Helaina is based in New York, NY.
What sector does Helaina operate in?: Helaina is tracked under Biotech from New York, NY, with $38M in disclosed funding.
When did Helaina last raise?: The last disclosed Helaina round closed in January 2024 at Series B.

Round data for Helaina is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in New York and backer lists below.

Helaina Funding: $38M Raised, Series B (2024)

Helaina funding overview

Helaina at a glance

Frequently asked about Helaina funding

Helaina founders (1)

Companies related to Helaina (40)

Browse related funding lists (6)